Next Article in Journal
Engineered Liposomal Delivery of Human ACE2 Across the Blood–Brain Barrier Attenuated Neurogenic Hypertension
Previous Article in Journal
Unique Features and Collateral Immune Effects of mRNA-LNP COVID-19 Vaccines: Plausible Mechanisms of Adverse Events and Complications
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(10), 1328; https://doi.org/10.3390/pharmaceutics17101328
Action Date Notes Link
article xml file uploaded 13 October 2025 16:44 CEST Original file -
article xml uploaded. 13 October 2025 16:44 CEST Update https://www.mdpi.com/1999-4923/17/10/1328/xml
article pdf uploaded. 13 October 2025 16:44 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1328/pdf
article html file updated 13 October 2025 16:45 CEST Original file https://www.mdpi.com/1999-4923/17/10/1328/html
Back to TopTop